Education Webinars
The ESM board have launched a series of Education Webinars to connect and stay in touch with our membership. The webinars are organised by ESM thanks to a generous contribution from our sponsors, who have not had any influence on content of the presentations.
Next Webinar
Dr Claudio Köser is a visiting scientist at the Department of Genetics, University of Cambridge. His main interest lies in bringing modern microbiological principles to defining susceptibility and resistance to anti-TB agents. This work revealed that the WHO breakpoints for several first- and second-line drugs had been too high, resulting in the systematic misclassification of resistant strains as susceptible. He is working closely with EUCAST and drug developers to avoid these shortcomings for new agents.
View ESM's previous Education Webinars via the links below. The webinars were organised by ESM thanks to generous contributions from BD and Qiagen, who have not had any influence on content of the presentations. We thank BD and Qiagen very much for their continuous support of our society.
Series 2: October 2021-January 2022
Biomarkers for incipient TB and disease progression and cure: today, tomorrow and future
Alberto Matteelli, University of Brescia and Brescia Spedali Civili General Hospital
Morten Ruhwald, FIND, Geneva
Unmet needs in screening for TB infection in high incidence/low resource settings: new tools and approaches.
Lele Rangaka, University College London
Series 2: May-June 2021
Sampling, Ordering and Logistics – the Keys of good TB diagnostics:
How to choose and collect the best TB samples and how to optimize ordering, reporting and transportation with the help of smart software solutions.
Harald Hoffmann, IML Red, Gautling Germany
Simon Tiberi, Barts Health NHS Trust, London
NTM (non-tuberculosis mycobacteria) Pulmonary disease, from diagnosis to treatment
Jakko van Ingen, RaboudUMC, Nijmegen
Three European healthcare system perspectives on TB diagnostics: setup and challenges in different settings
Florian Maurer, National Reference
Center for Mycobacteria, Borstel
Troels Lillebaek, Statens Serum Institut, Copenhagen
Natalia Shubladze, National Center for TB and Lung Diseases of Georgia
Series 1: September 2020
Role and value of NGS in TB diagnostic and clinical management: today, tomorrow and long-term
Vlad Nikolayevskyy, National Mycobacterum Reference Service South, Public Health England, London
Watch video (you will need to be logged into your ESM online account to view).
M. tuberculosis drug susceptibility testing: Genotypic vs Phenotypic approaches: What and How, Advantages and Limitations
Leen Rigouts, Institute of Tropical Medicine, Antwerp
Stefan Niemann, National Reference Center for Mycobacteria Forschungszentrum, Borstel
Drug susceptibility testing and treatment of NTM disease.
Jakko van Ingen, RaboudUMC, Nijmegen